fda decision on compounded tirzepatide Some patients now turn to copycat versions of popular weight loss drugs FDA sets tirzepatide compounding deadlines

Partial loss of psychiatric risk gene Mir137 in mice causes repetitive behavior and impairs sociability and learning via increased Pde10a

Clinical findings might include possible pernicious anaemia or neuropathy including subacute combined degeneration of the cord

There is interest in GLP-1 agonists and their ability to either reduce atherosclerotic plaque burden or the potential for plaque disruption- recognized as a proximate cause of arterial thrombotic events

Understanding both sides will help you have an informed conversation with your healthcare provider

This can be incredibly helpful for anyone struggling with overeating or emotional eating